A new research has suggested that most clinical trials of vitamin supplements, including some that concluded they are of no value or even harmful, have a flawed methodology, which makes them largely useless in determining the real value of these micronutrients.
Many projects have tried to study nutrients that are naturally available in the human diet the same way they would a powerful prescription drug.
Balz Frei, professor and director of the Linus Pauling Institute at Oregon State University, said that this leads to conclusions that have little scientific meaning, even less accuracy and often defy a wealth of other evidence.
Lead author Alexander Michels, an LPI research associate, said that in cell culture experiments that are commonly done in a high oxygen environment, vitamin C is unstable and can actually appear harmful.
He said that almost every animal in the world, unlike humans, is able to synthesize its own vitamin C and doesn't need to obtain it in the diet, which makes it difficult to do any lab animal tests with this vitamin that are relevant to humans.
The new review has been published in the journal Nutrients.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
